Benchmark Maintains Buy on Select Medical Hldgs, Raises Price Target to $42
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland maintains a Buy rating on Select Medical Holdings (SEM) and raises the price target from $39 to $42.
May 06, 2024 | 11:43 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Bill Sutherland maintains a Buy rating on Select Medical Holdings and raises the price target from $39 to $42.
The increase in price target by Benchmark analyst Bill Sutherland is a positive signal for investors, indicating a bullish outlook on the stock. This adjustment reflects an expectation of higher future performance or valuation for Select Medical Holdings, which could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100